Background: Traumatic brain injury (TBI) is considered a risk factor for the development of stroke (Hemorrhagic Stroke and Ischemic Stroke). We performed this systemic review and meta-analysis to determine the association of prior TBI with the subsequent diagnosis of stroke.Methods: We systematically searched PubMed, EMBASE, and the Cochrane Library for cohort studies involving TBI patients who subsequently developed stroke. Study selection, data extraction, and quality assessment were performed by two separate researchers. Data were analyzed with random-effects models, and a secondary analysis stratified by the type of stroke was performed.Results: Of the 741 identified studies, 6 studies were eligible for inclusion, with more than 2,200,000 participants. TBI predicted the occurrence of stroke in the random-effect model, with a relative risk of 2.14 (95% CI 1.97–2.32, P < 0.001). Furthermore, in the analysis of each type of stroke, TBI was associated with the incidence of ischemic stroke (RR 1.351 95% CI 1.212–1.506, P < 0.001), and TBI was associated with an even greater increase in the incidence of hemorrhagic stroke (RR 6.118 95% CI 5.265–7.108, P < 0.001).Conclusion: Our meta-analysis showed that TBI was associated with a more than two-fold increase in the risk of stroke. However, owing to the high degree of heterogeneity, decisions should be made on a patient-by-patient basis. The occurrence of TBI is associated with the development of both hemorrhagic and ischemic stroke, and the risk of hemorrhagic stroke is much higher than that of ischemic stroke in TBI patients.
Background: Ethylene oxide (EO) is a widely used industrial chemical recognized for its health risks, potentially posing threats to human health, including neurotoxicity, cardiovascular damage, and carcinogenic effects. Neurofilament light chain (NfL) is a protein released into the blood following axonal damage. To date, no studies have investigated the relationship between EO exposure and NfL levels. Therefore, we selected 5,902,013–2014 National Health and Nutrition Examination Survey (NHANES) participants to examine the relationship between blood EO levels and serum NfL concentrations.Methods: According to the data from NHANES, this cross-sectional study used multiple regression analysis, subgroup analysis, and smooth curve fitting to explore the relationship between Ethylene oxide and Neurofilament light chain.Results: The results of the present study indicate a positive association between EO exposure and NfL concentrations. Greater EO exposure was correlated with increased serum NfL concentrations in the fully adjusted model [β = 0.28, 95% CI (0.16, 0.40)]. Each additional unit of EO exposure was linked to a 0.28-unit increase in the serum NfL level. Additionally, IN sensitivity analysis by changing EO exposure from a continuous variable to a categorical variable. The serum NfL concentrations increased with increasing tertiles of EO levels. Compared with the lowest tertile, the highest EO exposure tertile was associated with a 0.28-unit increase in serum NfL concentrations (β = 0.28, 95% CI 0.16, 0.40; P for trend = 0.0138).Conclusion: Our results indicate a link between increased EO levels and higher serum NfL concentrations in a sample of US adults aged 20 years and older. Although the directionality and clinical significance of this observation remain uncertain, our results emphasize the importance of conducting additional studies to investigate the possible causes and neurological effects of exposure to EO in adults.
The field of genetics has yet to elucidate the complex genetic underpinnings that influence sleep quality. Previous studies have conducted genome-wide association studies (GWAS) on different dimensions of sleep health, but have not directly analyzed the multivariate genetic structure of poor sleep quality (PSQ). To address this knowledge gap, we employed a multifaceted approach that incorporated Genomic Structural Equation Modeling (Genomic-SEM) and multiple Post-GWAS methods. This strategy enabled us to identify causal single nucleotide polymorphisms (SNPs) that contribute to the variability in poor sleep quality. Our study identified a total of 14 leading SNP loci (such as rs2820309) and 3 fine-mapping significant loci (such as KTN1: rs77168063). To further investigate the underlying mechanisms, we employed multiple whole-transcriptome association methods. These methods analyzed susceptible gene signal loci that exhibited strong correlation with poor sleep quality, as determined by tissue, cell layer, and genome component analysis, along with related component information. Subsequently, data on approximately 13,000 common diseases were evaluated to determine the associated predisposing factors for poor sleep quality, and the correlation between poor sleep quality and 20 common neurological diseases was assessed. Additionally, we utilized a polygenic score based on summary data to analyze evidence of risk for poor sleep quality across different chromosomes. This study offers a novel perspective on the genetic underpinnings of poor sleep quality by conducting a genome-wide association study for a phenotype that was not directly measured.